Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Kuroda

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
World Neurosurgery|October 4, 2024
Calvarial Thickening in Tuberous Sclerosis ComplexHideki Kuroda, Hui Ming Khoo, Yuya Fujita, et al.
Oncology Letters|November 4, 2024
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting <i>MGMT</i> promoter methylation and prognostic value in newly diagnosed patients with glioblastomaDaiki Chida, Yoshiko Okita, Reina Utsugi, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2026
Intracranially injected chimeric antigen receptor T cells eradicate glioblastoma cells but have limited potential to persist in the brain in a syngeneic mouse modelKoki Murakami, Noriyuki Kijima, Hideki Kuroda, et al.
Plos One|January 10, 2025
Cerebral blood flow and histological analysis for the accurate differentiation of infiltrating tumor and vasogenic edema in glioblastomaHideki Kuroda, Yoshiko Okita, Atsuko Arisawa, et al.
Biochemical and Biophysical Research Communications|June 29, 2007
Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivityTsukasa Baba, Seiichi Mori, Noriomi Matsumura, et al.
Neurologia Medico-Chirurgica|February 18, 2026
Brain Lesions Associated with Human Immunodeficiency Virus Infection in the Antiretroviral Therapy Era: A Single-center Experience in JapanYosuke Fujimi, Katsunori Asai, Dai Watanabe, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2025
Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastomaHideki Kuroda, Noriyuki Kijima, Tetsuro Tachi, et al.
Journal of Neuroendovascular Therapy|March 24, 2025
Aneurysms Associated with Hyperplastic Anterior Choroidal Arteries: Three Cases with Literature ReviewTakahiro Uno, Katsunori Asai, Tomoki Kidani, et al.
Cancer Immunology, Immunotherapy : CII|October 5, 2024
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft modelTetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, et al.
Neuro-Oncology Advances|January 5, 2023
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapyTomoyoshi Nakagawa, Noriyuki Kijima, Kana Hasegawa, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
World Neurosurgery|October 4, 2024
Calvarial Thickening in Tuberous Sclerosis ComplexHideki Kuroda, Hui Ming Khoo, Yuya Fujita, et al.
Oncology Letters|November 4, 2024
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting <i>MGMT</i> promoter methylation and prognostic value in newly diagnosed patients with glioblastomaDaiki Chida, Yoshiko Okita, Reina Utsugi, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2026
Intracranially injected chimeric antigen receptor T cells eradicate glioblastoma cells but have limited potential to persist in the brain in a syngeneic mouse modelKoki Murakami, Noriyuki Kijima, Hideki Kuroda, et al.
Plos One|January 10, 2025
Cerebral blood flow and histological analysis for the accurate differentiation of infiltrating tumor and vasogenic edema in glioblastomaHideki Kuroda, Yoshiko Okita, Atsuko Arisawa, et al.
Biochemical and Biophysical Research Communications|June 29, 2007
Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivityTsukasa Baba, Seiichi Mori, Noriomi Matsumura, et al.
Neurologia Medico-Chirurgica|February 18, 2026
Brain Lesions Associated with Human Immunodeficiency Virus Infection in the Antiretroviral Therapy Era: A Single-center Experience in JapanYosuke Fujimi, Katsunori Asai, Dai Watanabe, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2025
Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastomaHideki Kuroda, Noriyuki Kijima, Tetsuro Tachi, et al.
Journal of Neuroendovascular Therapy|March 24, 2025
Aneurysms Associated with Hyperplastic Anterior Choroidal Arteries: Three Cases with Literature ReviewTakahiro Uno, Katsunori Asai, Tomoki Kidani, et al.
Cancer Immunology, Immunotherapy : CII|October 5, 2024
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft modelTetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, et al.
Neuro-Oncology Advances|January 5, 2023
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapyTomoyoshi Nakagawa, Noriyuki Kijima, Kana Hasegawa, et al.
Pageof 3